ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Alphabet's Isomorphic Labs and MSD team up on an AI-led cancer drug discovery project. Isomorphic Labs receives an upfront payment and future milestone payments. The company recently raised $5bn in Series C funding led by Greenoaks and Sequoia Capital.
Tap to vote and see what everyone thinks.
Summary by ByteBrief